May 05, 2021 10:24 AM IST
In September 2020, the Bill and Melinda Gates Foundation provided $150 million to the Pune-based vaccine-maker to fund the additional 10 crore COVID-19 vaccine doses.
- May 04, 2021 03:45 PM IST
The ICMR and SII are jointly performing a phase-2/3 observer-blind, randomised, controlled study to determine the safety and efficacy of the Covovax vaccine.
- May 04, 2021 09:38 AM IST
The announcement comes a couple of hours ahead of a virtual bilateral summit between Prime Minister Narendra Modi and his British counterpart Boris Johnson. SII is already running phase 1 trials of its new one dose nasal vaccine in the UK, which may be produced in the country once approved.
- May 03, 2021 02:11 PM IST
The Serum Institute has been maligned by politicians and critics over the vaccine shortages, Adar Poonawalla tells Financial Times. "I have been victimised very unfairly and wrongly."
- May 02, 2021 08:32 AM IST
Serum Institute of India CEO Adar Poonawalla also confirmed that he had “an excellent meeting” with all partners and stakeholders in the United Kingdom.
- May 01, 2021 07:32 PM IST
Serum Institute of India boss Adar Poonawalla in interview to London Times reveals why he is in the UK and talks about the pressure to deliver vaccines in India.
- Apr 28, 2021 01:06 PM IST
The PIL, filed on April 24 by advocate Fayzan Khan and three law students, said the vaccine is presumed to be an essential commodity and hence its management and distribution cannot be left in the hands of private companies.
- Apr 24, 2021 01:50 PM IST
A look at yesterday's meeting between state chief ministers and Prime Minister Narendra Modi, beyond the television coverage.
- Apr 22, 2021 09:20 PM IST
The Chief Minister gave instructions to strengthen the helpline, aimed at immediately responding to issues faced by the people.
- Apr 22, 2021 05:53 PM IST
Gorakhpur MLA Radha Mohan Das Agrawal made the remarks after SII on Wednesday announced a price of Rs 600 per dose for Covishield supplies to private hospitals and Rs 400 per dose to state governments.
- Apr 20, 2021 02:00 PM IST
Adar Poonawalla's tweet came a day after the Centre approved an advance of around Rs 3,000 crore to the Serum Institute of India. Poonawalla had earlier said that the amount would be needed to ramp up production capacity.
- Apr 19, 2021 09:19 PM IST
“The Finance Ministry today has relaxed the general financial rules and permitted the Ministry of Health to pay, if they so wish, to make advance payment to vaccine suppliers, without a bank guarantee. I believe the Health Ministry is already doing so,” a top official told Moneycontrol
- Apr 16, 2021 04:17 PM IST
The difference of opinion has especially widened on whether the dire situation at hand requires the government to provide direct funding to the largest vaccine maker in the world.
- Apr 16, 2021 02:34 PM IST
"I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up. Your administration has the details," Poonawalla tweeted.
- Apr 12, 2021 11:06 AM IST
Many have argued for a ban on the commercial export of Covid-19 vaccines from India, as the second wave of the pandemic continues to infect a record number of people every day and vaccine shortages have been reported from multiple States. But the government is not keen on the proposal since both the manufacturers in India are legally obligated to fulfil contracts to supply doses to foreign buyers, and a large chunk of the global poor are dependent on India’s vaccines.
- Apr 09, 2021 03:46 PM IST
The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200 million committed, and the rest on option.
- Apr 08, 2021 08:18 PM IST
The WHO has also sought a meeting with Drugs Controller General of India (DCGI) to discuss the matter, sources said.
- Apr 08, 2021 05:28 PM IST
India has won enormous diplomatic goodwill with free supply of vaccines to poor countries but as daily new cases continue to soar to new record, the government is facing pressure to increase domestic supply and expand the inoculation programme that is so far restricted to people who are at least 45 years old.
- Apr 08, 2021 10:22 AM IST
SII will prioritise supplies to India over the next one or two months, Poonawalla has said.
- Apr 07, 2021 07:19 PM IST
About 90 percent of the 86 million doses India has administered since mid-January have come from the Serum Institute of India, with the rest accounted for by a domestic vaccine developed by Bharat Biotech, which is also struggling to boost output.
- Apr 05, 2021 09:27 AM IST
SII might apply for marketing authorisation of the COVID-19 vaccine to the CDSCO by the end of April.
- Apr 01, 2021 07:00 PM IST
The EU wants the doses from Serum, the world's largest vaccine maker, to offset supply shortfalls from AstraZeneca's European plants and speed up the bloc's vaccine roll-out.
- Mar 27, 2021 08:34 PM IST
India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by Serum Institute of India (SII), prioritising domestic demand as infections rise.
- Mar 25, 2021 06:03 PM IST
The AstraZeneca-Oxford vaccine is being produced under licence in India for the Covax scheme, also led by the World Health Organization (WHO), which is meant to ensure that low-income countries can access COVID-19 jabs.
- Mar 24, 2021 09:13 PM IST
Indian Prime Minister Narendra Modi's cabinet decided this week to widen its inoculation drive by including everyone above 45 from April 1, and many states battling a surge in infections have demanded that all adults be covered.